Events

Apex EMEA Family Office Symposium w/ Joanna Shields

Joanna Shields, CEO of BenevolentAI, will speak on a panel on the future of healthcare.

BenevolentAI’s CEO, Joanna Shields, will be speaking on the Goldman Sachs Future of Healthcare panel at the Apex EMEA Family Office Symposium in London on October 19, 2022. The panel will be moderated by Ben Thorpe, Co-Head of Healthcare Investment Banking EMEA, Goldman Sachs.

Panel Speakers:

  • Joanna Shields, Baroness Shields, OBE, CEO, Benevolent AI
  • Ranjan Singh, Co-Founder and CEO, HealthHero
  • Simeon George, CEO and Managing Partner, SR One


Joanna Shields

Chief Executive Officer

Joanna is passionate about creating technology that benefits humanity. She has spent her professional life building companies, products and platforms that have transformed markets and reshaped industries. She has been CEO of BenevolentAI since 2018 and has accelerated the company’s growth from a startup to a clinical-stage, AI-enabled drug discovery company. Joanna has over three decades of experience leading some of the world's best known technology companies, including Facebook, Bebo/Aol and Google. Prior to joining BenevolentAI, Joanna served in the UK Government as Under Secretary of State and Minister for Internet Safety & Security, Digital Economy Adviser and UK Ambassador for Digital Industries. Joanna is the founder of the WeProtect Global Alliance, serves as the Co-Chair of the Global Partnership on Artificial Intelligence (GPAI) and is a Life Peer of the House of Lords.

More Posts

You Might Also Like

News
BenevolentAI to present at 41st Annual J.P. Morgan Healthcare Conference
BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, US from 9-12 January 2023.
Dec 1, 2022
Blog
FAIR Data Foundation: An Enabler for AI Drug Discovery
Biomedical data used in AI-enabled drug discovery should adhere to the FAIR Data Principles — Findability, Accessibility, Interoperability and Reusability. This blog explains why this is, how one can make data FAIR and challenges that remain.
Nov 8, 2022
News
BenevolentAI to present at Jefferies Investor Conference in November
BenevolentAI’s Investor Relations and Business Development team will be attending the Jefferies Healthcare London conference, with Nick Keher, CFO, presenting on Thursday 17th November.
Nov 4, 2022
News
BenevolentAI achieves further milestones in AI-enabled target identification collaboration with AstraZeneca
Two additional AI-generated novel targets selected by AstraZeneca for its drug development portfolio, resulting in two milestone payments for BenevolentAI.
Oct 6, 2022
News
Interim results for the six months ended 30 June 2022
Continued operational progress and strengthened financial position provides capital for key value inflection points and continued investment in leading technology platform.
Sep 27, 2022
News
Analyst / Investor Event
BenevolentAI announces that during its analyst / investor event and interim results presentation being held in London today, new information on the Company’s BEN-2293 Phase Ib study results will be disclosed.
Sep 27, 2022